The science behind the lawsuit The patients suing Novo Nordisk and Eli Lilly claim that the drugs increase the risk of serious, long-lasting digestive problems, about which they were not properly warned
Its also easier to miss, because symptoms may look like just being tired or a little off today, especially in someone who already has memory or balance problems
What the Research Shows The approval was based on impressive results from the SURMOUNT-OSA clinical trials involving 469 adults: For people NOT using CPAP machines: Tirzepatide reduced breathing interruptions by 25 events per hour Placebo only reduced interruptions by 5 events per hour 42% achieved remission or mild symptoms after one year For people USING CPAP machines: Tirzepatide reduced breathing interruptions by 29 events per hour Placebo only reduced interruptions by 6 events per hour 50% achieved remission or mild symptoms after one year Beyond Sleep Apnea While sleep apnea research is most advanced, early evidence suggests GLP-1 medications may help with other sleep problems too: Reduced insomnia symptoms Less tossing and turning at night Improved deep sleep quality Better daytime energy levels Who Can Benefit From GLP-1 Therapy for Sleep
Required fields are marked * Your review * Name * Email * Save my name, email, and website in this browser for the next time I comment.
Another advantage of Tirzepatide is its potential to further improve insulin sensitivity, making it especially beneficial for individuals with insulin resistance or those at risk of developing type 2 diabetes
Frequently Asked Questions Can I use my GLP-1 pen if it has been left out of the fridge overnight
